Dr. Daniel Vitt

Dr. Daniel Vitt is the current CEO and President at Immunic Therapeutics. Prior to this, they were with 4SC AG from August 1997 to December 2016 where they were a co-founder and the CSO for almost 20 years.

Dr. Daniel Vitt received their undergraduate degree in Chemistry from the Julius Maximilians University of Würzburg. Dr. then went on to earn their PhD in Organic Chemistry from Universität Siegen. After completing their PhD, they worked as a postdoctoral researcher at the FJM Siegen.

and Jessica Breu - Head of Investor Relations and Communications reports to Dr. Daniel Vitt.